Equities research analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Friday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens upped their price objective on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
View Our Latest Stock Report on Veradigm
Veradigm Trading Down 1.5 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Business Services Stocks Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Growth Stocks: What They Are, Examples and How to Invest
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
